LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 79 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2019. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $10,193,000 | -33.5% | 1,158,271 | -30.1% | 1.76% | -4.1% |
| Q2 2019 | $15,329,000 | +35.5% | 1,657,171 | -5.8% | 1.83% | +34.8% |
| Q1 2019 | $11,311,000 | -31.8% | 1,759,171 | 0.0% | 1.36% | -39.7% |
| Q4 2018 | $16,589,000 | -50.0% | 1,759,171 | +6.7% | 2.26% | -36.0% |
| Q3 2018 | $33,190,000 | -13.3% | 1,648,772 | +25.6% | 3.52% | -17.7% |
| Q2 2018 | $38,303,000 | +14.0% | 1,313,105 | +16.4% | 4.28% | +16.2% |
| Q1 2018 | $33,598,000 | +22.2% | 1,128,219 | +32.1% | 3.68% | +7.2% |
| Q4 2017 | $27,491,000 | +31.4% | 854,301 | +42.0% | 3.44% | +27.5% |
| Q3 2017 | $20,920,000 | +19.1% | 601,500 | +2.0% | 2.70% | +40.3% |
| Q2 2017 | $17,563,000 | +647.7% | 589,959 | +649.6% | 1.92% | +601.1% |
| Q1 2017 | $2,349,000 | – | 78,700 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
| TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
| RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
| Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
| Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
| WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
| FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
| HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
| Summit Global Investments | 48,500 | $208,000 | 0.01% |